Abingdon US subsidiary enters tax credit deal in Wisconsin

(Sharecast News) - Abingdon Health said on Wednesday that its US subsidiary had entered into a tax credit agreement with the Wisconsin Economic Development Corporation to support the expansion of its operations in Madison.

The AIM-traded rapid diagnostics and med-tech services group said Abingdon Health USA had been certified as eligible to earn up to $370,000 in performance-based Wisconsin tax credits over three years from 1 January 2026.

The credits comprise up to $320,000 linked to the creation of new full-time roles and up to $50,000 linked to qualifying capital investment at the group's facilities in Wisconsin.

The final amount received will depend on the number of jobs created and the level of capital investment made.

Abingdon said the award reflected the continued growth of its US operations and supported the expansion of its facilities at University Research Park in Madison, which serve as its North American base for development, manufacturing and commercial activity.

John Miller, secretary and chief executive of WEDC, said Abingdon's decision to locate and grow in Wisconsin reflected the strength of the state's biohealth and biotechnology sector, research institutions and workforce.

Chris Yates, president of Abingdon Health USA, said the award was "a welcome endorsement" of the company's commitment to Wisconsin and its position in the US market.

"These tax credits will support our expansion at University Research Park in Madison, including the creation of additional skilled roles as Abingdon Health USA continues to grow to meet customer demand across the United States," he said.

At 1144 BST, shares in Abingdon Health were down 4.04% at 11.52p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Abingdon Healt.